Protota Pharmaceuticals Private Limited
About Protota Pharmaceuticals Private Limited
Data last updated:
Protota Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the manufacturing segment of the food and beverages sector. It was incorporated on 05 October 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24304MH2018PTC315326. Its GSTIN is 27AAKCP1231H1ZK (Maharashtra).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Meena Surinder Dang and Surinder Dang.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 601 Sanctura Wing Senroof Projects Off Goregaon Mulund Link Road Mulund (E), Mumbai, Maharashtra, India – 400081.
As per the financials filed for FY 2024, the company reported a revenue of ₹3.37 Cr, a decline of 18% compared to the previous year. For the same year it recorded a net profit of ₹89,308 (net margin 0.3%) and EBITDA of ₹89,308 (EBITDA margin 0.3%).
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address601 Sanctura Wing Senroof Projects Off Goregaon Mulund Link Road Mulund (E), Mumbai, Maharashtra, India – 400081
- IndustryFood And Beverages, Manufacturing, Artificial Fibres
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Protota Pharmaceuticals Private Limited
The main business activity of Protota Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Protota Pharmaceuticals Private Limited FY 2024 filings available
Protota Pharmaceuticals Private Limited reported revenue of ₹3.37 Cr (down 18% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Protota Pharmaceuticals Private Limited
Revenue fell 18% in the latest year. EBITDA rose 174% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Protota Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹89,308 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹89,308 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Protota Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Protota Pharmaceuticals are in the company report.
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Protota Pharmaceuticals Private Limited
Protota Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Tyscon Pharmaceuticals Private Limited | ₹3.4 Cr (FY 2025) | •••• | •••• | 16.0% | •••• | Zirakpur, Punjab, India |
| Maxzimaa Pharmaceuticals Private Limited | ₹3.4 Cr (FY 2025) | •••• | •••• | 0.0% | •••• | New Delhi, Delhi, India |
| Centenary Pharmaceuticals Private Limited | ₹3.4 Cr (FY 2025) | •••• | •••• | 49.0% | •••• | Pune, Maharashtra, India |
| Saach Pharmaceuticals Private Limited | ₹3.39 Cr (FY 2024) | •••• | •••• | 17.0% | •••• | Manimajra, Chandigarh, India |
| Bio Trans Pharmaceuticals Private Limited | ₹3.37 Cr (FY 2024) | •••• | •••• | -8.0% | •••• | Athipattu, Tamil Nadu, India |
| Protota Pharmaceuticals Private Limited this company | ₹3.37 Cr (FY 2024) | •••• | •••• | -18.0% | •••• | Mumbai, Maharashtra, India |
| Eshwar Pharmaceuticals Private Limited | ₹3.36 Cr (FY 2018) | •••• | •••• | -35.0% | •••• | Hyderabad, Telangana, India |
| Apdm Pharmaceuticals Private Limited | ₹3.36 Cr (FY 2024) | •••• | •••• | •••• | Ahmedabad, Gujarat, India | |
| Azcad Pharmaceuticals Private Limited | ₹3.36 Cr (FY 2025) | •••• | •••• | 10.0% | •••• | Chennai, Tamil Nadu, India |
| Thundersky Pharmaceuticals Private Limited | ₹3.35 Cr (FY 2025) | •••• | •••• | 894.0% | •••• | Anklav, Gujarat, India |
| Teaspoon Pharmaceuticals (India) Private Limited | ₹3.35 Cr (FY 2025) | •••• | •••• | 10.0% | •••• | Barabanki, Uttar Pradesh, India |
Peers are the five companies nearest above and the five nearest below Protota Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Protota Pharmaceuticals Private Limited
Protota Pharmaceuticals has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Meena Surinder Dang Also directs: Kaori Consultants LLP | Director | 05 Oct 2018 | 8 Years 0 Months | Current |
| Surinder Dang Also directs: Kaori Consultants LLP | Director | 05 Oct 2018 | 8 Years 0 Months | Current |
| Anmol Surinder Dang Also directs: Kaori Consultants LLP | Director | 05 Oct 2018 | 8 Years 0 Months | Current |
| Charchit Surinder Dang Also directs: Kaori Consultants LLP | Director | 05 Oct 2018 | 8 Years 0 Months | Current |
Ownership and Shareholding of Protota Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Protota Pharmaceuticals Private Limited
Protota Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Protota Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Protota Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Protota Pharmaceuticals Private Limited
Protota Pharmaceuticals Private Limited has 4 board changes on record since 2018: 4 appointments. The latest: Anmol Surinder Dang was appointed as Director on 05 Oct 2018.
Credit Ratings, Litigation & Regulatory Alerts for Protota Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Protota Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Protota Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Protota Pharmaceuticals Private Limited
Protota Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAKCP1231H1ZK | Maharashtra | Active | 09 Apr 2021 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Protota Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Protota Pharmaceuticals Private Limited
Protota Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in manufacturing, within the food and beverages industry. It was incorporated on 05 October 2018 (8+ years old) and is registered under CIN U24304MH2018PTC315326.
Protota Pharmaceuticals reported revenue of ₹3.37 Cr for FY 2024 (down 18% YoY).
Protota Pharmaceuticals has 4 current directors:
- Meena Surinder Dang - Director
- Surinder Dang - Director
- Anmol Surinder Dang - Director
- Charchit Surinder Dang - Director
Protota Pharmaceuticals reported a net profit of ₹89,308 (net margin 0.3%) and EBITDA of ₹89,308 (EBITDA margin 0.3%) for FY 2024, as per its filed financial statements.
The GSTIN of Protota Pharmaceuticals is 27AAKCP1231H1ZK, registered in Maharashtra.
The CIN (Corporate Identification Number) of Protota Pharmaceuticals is U24304MH2018PTC315326. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Protota Pharmaceuticals was incorporated on 05 October 2018, making it 8+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Protota Pharmaceuticals by revenue are Tyscon Pharmaceuticals Private Limited, Maxzimaa Pharmaceuticals Private Limited, Centenary Pharmaceuticals Private Limited, Saach Pharmaceuticals Private Limited, Bio Trans Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Anmol Surinder Dang was appointed as Director on 05 Oct 2018. Charchit Surinder Dang was appointed as Director on 05 Oct 2018. Meena Surinder Dang was appointed as Director on 05 Oct 2018. Protota Pharmaceuticals has 4 board changes on record in total.
The registered office of Protota Pharmaceuticals is at 601 Sanctura Wing Senroof Projects Off Goregaon Mulund Link Road Mulund E, Mumbai, Maharashtra, India – 400081.
Protota Pharmaceuticals has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh.